Bayer Schering Pharma to invest 100 million Euro in China to build a global R&D center
- Details
- Category: Bayer

HemCon Announces Further Successful Results from Live Nail Infection Anti-Fungal Study
- Details
- Category: Product
HemCon Medical Technologies, Inc. has announced results from an independent study investigating the time required to successfully treat fungal infected human nails which is a leading cause of Onychomycosis. The studies were conducted as part of HemCon's continued program of development for a formulation based on its newest proprietary platform technology.
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
- Details
- Category: Eli Lilly and Company

Pfizer to Disclose Payments to US Physicians, Healthcare Professionals and Clinical Investigators
- Details
- Category: Pfizer

GlaxoSmithKline and Idenix Pharmaceuticals sign worldwide license agreement for IDX899
- Details
- Category: GlaxoSmithKline

Lundbeck to acquire US-based Ovation Pharmaceuticals, Inc.
- Details
- Category: Lundbeck

Pfizer and The Pfizer Foundation Recognize "World Cancer Day"
- Details
- Category: Pfizer

More Pharma News ...
- European Commission (EC) has granted marketing authorisation for Nplate(R) (romiplostim)
- European Commission Clears Acquisition of Zentiva NV by sanofi-aventis
- Strong operating results for Roche in 2008
- Roche Announces Interim Results from a Phase III ATLAS Study
- Lipitor Significantly Reduced hsCRP Levels in Patients with Stable Coronary Artery Disease
- Novartis increases dividend by 25% based on strong 2008 results
- Pfizer Discontinues Global Phase III Trial of Axitinib